Slide 1: First Quarter 2025 Financial Results
May 13, 2025 First Quarter 2025 Financial Results
Slide 2: Welcome and Participants
Welcome and Participants Dr. Jeffrey Graves President & Chief Executive Officer Jeffrey Creech Executive Vice President & Chief Financial Officer Mick McCloskey Vice President, Treasury & Investor Relations To participate via phone, please dial: 1-201-689-8345 2
Slide 3: Forward Looking Statements
Forward Looking Statements Certain statements made in this presentation that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncert
Slide 4: Dr. Jeffrey Graves
Dr. Jeffrey Graves President & Chief Executive Officer 4
Slide 5: Short-Term Revenue Pressure Masks Long-Term Opportunity
Short-Term Revenue Pressure Masks Long-Term Opportunity • Revenues impacted by global tariff uncertainty and frozen CapEx investments • Underlying demand for additive remains strong and inevitable – continue to see strength in personalized healthcare, defense and AI infrastructure markets Additive M
Slide 6: Driving Metals Growth Through Innovation & Execution
Driving Metals Growth Through Innovation & Execution • Services & Hardware Growth Validate Strategic Advantage & Portfolio Breadth Despite economic headwinds, growth in systems demonstrates strength of new products and early feedback on long-term growth strategy • Application Innovation Group (AIG)
Slide 7: Accelerating Growth in Personalized Healthcare & Parts Manufacturing
Accelerating Growth in Personalized Healthcare & Parts Manufacturing • Strong revenue growth in strategic focus areas for Healthcare Solutions – Personalized Healthcare +17% YoY & medical parts manufacturing +18% YoY • Deep Industry Partnerships Drive Innovation – Collaborations with industry leader
Slide 8: CEO Closing Remarks
CEO Closing Remarks ➢ Taking a prudent and conservative approach to planning, including withdrawing 2025 guidance due to tariff-related uncertainty ➢ Executing a dual-track cost reduction strategy targeting ~$70 million in savings − $50 million from ongoing efficiency initiatives − Incremental $20 m
Slide 9: Jeffrey Creech
Jeffrey Creech Chief Financial Officer 9
Slide 10: Q1 Revenue Summary
Q1 Revenue Summary ($ in millions) Industrial Solutions Healthcare Solutions Consolidated $57 $53 $45 $41 $103 $95 Q1’24 Q1’25 Q1’24 Q1’25 Q1’24 Q1’25 • ISG decreased ~7% YoY primarily • HSG declined ~9% YoY primarily • YoY revenue decreased ~8% as driven by decline in materials and driven by a decl
Slide 11: Gross Profit Margin
Gross Profit Margin (Non-GAAP) 40.1% First Quarter Drivers 35.0% • Lower volumes and unfavorable price/mix Cost Initiatives Expected to Drive Long-Term Benefit to GM% • Footprint consolidation • Factory utilization & inventory controls • Logistics efficiencies Q1'24 Q1'25 11 See Appendix for a recon
Slide 12: Operating Expense
Operating Expense (Non-GAAP) ($ in millions) ~$5mm improvement First Quarter Drivers • YoY improvement primarily driven by cost reduction actions • Continued improvement expected based on announced cost improvement actions $66.3 $61.6 Q1'24 Q1'25 12 See Appendix for a reconciliation of Non-GAAP Oper
Slide 13: Earnings (Non-GAAP)
Earnings (Non-GAAP) ($ in millions, except per share amounts) Q1’24 Q1’25 Q1 Drivers • Primarily driven by revenue and gross margin in Adj. EBITDA ($20.1) ($23.9) connection with lower volumes and less favorable price/mix Non-GAAP Diluted loss per ($0.17) ($0.21) • Partially offset by cost initiativ
Slide 14: Balance Sheet
Balance Sheet ($ in millions) Cash & Cash Equivalents • Q1’25 cash used in operations includes ~$10mm of items outside of normal quarterly operations (e.g. accelerated inventory purchases, compliance requirements, facilities Geomagic sale proceeds closures, etc.) ~$250 • April 2025 Month End Cash ~$
Slide 15: Closing Remarks Q&A Session
Closing Remarks + Q&A Session 1-201-689-8345 15
Slide 16: Thank You
Thank You Find out more at: www.3dsystems.com 16
Slide 17: Appendix
Appendix ©2025 3D Systems, Inc. | All Rights Reserved.
Slide 18: Presentation of Information
Presentation of Information 3D Systems reports its financial results in accordance with GAAP. Management also reviews and reports certain Non-GAAP measures, including: Non-GAAP revenue excluding divestitures and on a constant currency basis (sometimes referred to as excluding divestitures and FX eff
Slide 19: Appendix
Appendix 3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures Non-GAAP Gross Profit and Gross Profit Margin (unaudited) Three Months Ended (in millions) March 31, 2025 March 31, 2024 Gross Profit Siren Gross Profit Strain Gross profit GAAP) $s 32.7 34.6% $ 40.9 39.8% Amortiz
Slide 20: Appendix
Appendix 3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures Net Loss Attributable to 3D Systems Corporation to Adjusted EBITDA (unaudited) (in miltions) Net loss attributable to 3D Systems Corporation (GAAP) Interest income, net Provision for income taxes Depreciation expe